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Early age at first sexual intercourse (AFSI) has long been associated with an increased risk of invasive cervical carcinoma (ICC). Age at
first pregnancy (AFP) and ICC have been investigated less, although AFSI and AFP are strongly interrelated in most developing
countries. A pooled analysis of case–control studies on ICC from eight developing countries with 1864 cases and 1719 controls
investigated the roles of AFSI, AFP, and ICC risk. Age at first sexual intercourse, AFP and age at first marriage (AFM) were highly
interrelated and had similar ICC risk estimates. Compared with women with AFSI X21 years, the odds ratio (OR) of ICC was 1.80
(95% CI: 1.50–2.39) among women with AFSI 17–20 years and 2.31 (95% CI: 1.85–2.87) for AFSI p16 years (P-trend o0.001).
No statistical interaction was detected between AFSI and any established risk factors for ICC. The ICC risk was 2.4-fold among those
who reported AFSI and AFP at p16 years compared with those with AFSI and AFP at X21 years. These data confirm AFSI and AFB
as risk factors for ICC in eight developing countries, but any independent effects of these two events could not be distinguished.
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Early age at first sexual intercourse (AFSI) has been associated
with an increased risk of high-risk human papillomavirus (HPV)
infection, a sexually transmitted infection (STIS), that in
susceptible women is responsible for virtually all cases of invasive
cervical cancer (ICC) (Bosch et al, 2002). As sexual behaviour
determines exposure to HPV, AFSI is of particular interest as it has
been associated with riskier sexual behaviour, such as having
unprotected sex, having multiple sexual partners, as well as a
woman’s partner having multiple partners. It has also been
speculated that the increased risk of HPV is because of a biological
predisposition of the immature cervix during adolescence that may
be more susceptible to persistent HPV infections and therefore
have a greater risk of cancer development (Kjaer et al, 1998).
A number of studies have identified an increased risk of high-grade
lesions and/or cervical cancer with early AFSI, whereas others have
not (IARC, 2007). However, many of these studies were conducted
before HPV assessment was feasible, and therefore, the association
remains inconclusive. Age at first marriage (AFM) is often used as a
proxy measure for AFSI, and those who engage in early sexual
intercourse may also consequently become pregnant at an early age.
Besides early AFSI, early childbearing has also been linked as a risk
factor for cervical carcinogenesis and attributed to the cervical
trauma experienced during early age at first pregnancy (AFP), or
subsequently, by high-parity births (IARC, 2007). The interpretation
of the mechanisms by which these sexual and reproductive events
occurring early in life might affect ICC risk three or more decades
later is not straightforward. The objective of this study is to further
characterise and provide robust estimates of the risk of cervical
cancer and its association with AFSI, interrelated characteristics
such as AFP and AFM in a series of studies that fully considered the
association of HPV with cervical cancer.
MATERIALS AND METHODS
The programme of HPV and cervical cancer studies has been
coordinated by the International Agency for Research on Cancer
(IARC) in Lyon, France and the Institut Catala ` d’Oncologia (ICO)
in Barcelona, Spain. They included a series of case-control studies
on ICC from eight developing countries with a broad range of rates
of incidence of cervical cancer that were pooled for analysis.
Regions covered include Morocco (Chaouki et al, 1998) and
Algeria (Hammouda et al, 2005) in Africa; the Philippines
(Ngelangel et al, 1998), Thailand (Chichareon et al, 1998) and
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yMadras in Asia; and Brazil (Eluf-Neto et al, 1994), Colombia
(Munoz et al, 1993), Paraguay (Rolon et al, 2000) and Peru
(Eluf-Neto et al, 1994) in South America. Although Spain (Munoz
et al, 1993) was part of the series of case–control studies, the
sexual and reproductive behaviour of this population was
heterogeneous to the other countries (late AFSI and low parity)
and the study site was therefore excluded from this analysis.
The methods of each study have been described elsewhere.
Briefly, women with histologically confirmed incident invasive
squamous cell carcinoma (SCC), adenocarcinoma or adeno-
squamous-cell carcinoma were recruited from reference hospitals
before treatment. Written informed consent was obtained from
those who agreed to participate. Hospital-based controls were
frequency-matched to case patients by 5-year age groups.
A standardised questionnaire was administered to the partici-
pants by a trained interviewer, which included questions about
sociodemographic factors, sexual and reproductive behaviour,
smoking habits, pap screening history, hygienic practices, and
history of sexually transmitted diseases.
Two samples of cervical exfoliated cells were collected with
wooden spatulae and endocervical brushes. After preparation of
one Papanicolaou smear, the remaining cells were eluded in saline,
centrifuged and frozen at  701C until shipment to the central
laboratory for HPV DNA testing. A tumor-biopsy sample was
obtained from cases and frozen. Cytology and histology diagnoses
were reviewed and confirmed by a panel of expert pathologists that
agreed on a diagnosis by consensus or majority.
Detailed descriptions of the polymerase-chain-reaction (PCR)
assays used in these studies have been described elsewhere. HPV
DNA detection was detected by PCR amplification of a small
fragment of the L1 gene using MY09 and MY11 consensus primers
for the study in Colombia (Hildesheim et al, 1994) and the
GP5þ/6þ general primer system for the other studies
(Walboomers et al, 1992; Jacobs et al, 1995; Roda Husman et al,
1995). b-Globin primers were used to amplify the b-globin gene to
assess the quality of the DNA in the specimen. HPV DNA in PCR
products was analysed using a cocktail of HPV-specific probes and
genotyped by hybridisation with type-specific probes for 33 HPV
types. Samples that tested positive for HPV DNA but did not
hybridise with any of the type-specific probes were labelled as
HPV X.
Statistical analysis
Unconditional logistic regression was used to estimate odds ratios
(ORs) and 95% confidence intervals (95% CI). To assess the
association of AFSI with the risk of ICC, three different statistical
models to adjust for HPV DNA detection were computed and
compared: (1) one model included all patients and controls, and it
was not adjusted for HPV DNA status, (2) a second model included
all patients and controls, and included a variable to adjust for HPV
DNA status, and (3) a third model was restricted to HPV–DNA-
positive cases and controls. To control for potential confounding,
final models were adjusted for age (o40, X40), country, lifetime
number of sexual partners (1,41), parity (0, 1–4,X5), and
educational level (never, primary, secondary or higher). Each
variable included in the adjustment models was assessed for
interaction with AFSI. Test for trend was carried out when
appropriate, using the log-likelihood-ratio test. Only subjects who
reported ever having been married and/or ever having had
children were included in the analyses of AFM and AFP.
We evaluated other potential confounding factors such as
smoking (never, ever), oral contraceptive use (never, 1–4 years,
X5 years), history of pap smears excluding those in the 12 months
before enrolment (never, ever), having had first sexual intercourse
before menarche and the timing of first sexual intercourse relative
to age at menarche (data not shown), but they were not adjusted
for in the final analysis as they did not contribute any change to
the OR estimates for AFSI in the adjusted models.
RESULTS
Table 1 describes some characteristics of the 1864 ICC cases and
1719 corresponding controls that entered the final analysis.
Ninety-five percent of case patients and 17% of controls tested
positive for HPV DNA. The majority of cases (92%) had SCC. Case
patients were older than controls with a median age of 49 vs 48,
respectively. Median AFSI was earlier in case patients (17 years)
compared with controls (19 years), and this was found to be
consistent in each country.
Table 2 shows the risk of ICC by AFSI according to the three
different adjustment models. An increased risk of ICC was
consistently observed with decreasing AFSI (P-trend o0.001).
Compared with AFSI X21 years, the OR of ICC was 1.80 (95% CI:
1.50–2.16) for AFSI 17–20 years, and 2.31 (95% CI: 1.85–2.87) for
AFSI p16 years, after adjusting for age, centre, lifetime number
of partners, parity, and education level in the HPV-unadjusted
model. According to the different model adjustments, women
reporting AFSI p16 years of age had a 2.3–2.5-fold risk of ICC and
1.8–2.1-fold risk for AFSI 17–20 years of age (Table 2). Given
the consistent association of AFSI and the risk of ICC across
the different models, HPV-unadjusted models were used for the
remainder of the results.
We calculated the risk of ICC for each country study, and, in
general, each study showed an increasing risk of ICC with
decreasing AFSI (data not shown). There was no evidence of
heterogeneity with respect to study country (P¼0.58).
Table 1 Characteristics of cases of invasive cervix carcinoma and controls
HPV tested HPV positive Age
a Age at sexual debut
a
Cases Controls Cases % Controls % Cases Controls Cases Controls
Country 1864 1719 1769 94.9 285 16.6 49 48 17 19
Algeria 142 145 132 93.0 18 12.4 53.5 52 16 18
Morocco 188 176 182 96.8 38 21.6 49 40 16 18
Madras (India) 187 184 180 96.3 51 27.7 48 46.5 17 18
Philippines 364 380 349 95.9 35 9.2 47.5 47 19 21
Thailand 378 259 363 96.0 41 15.8 49.5 50 18 20
Brazil 187 190 181 96.8 32 16.8 51 52 18 19
Colombia 110 124 87 79.1 21 16.9 46 45.5 17 18
Paraguay 112 86 109 97.3 18 20.9 48.5 45.5 16 19
Peru 196 175 186 94.9 31 17.7 48 48 16 18
Abbreviation: HPV¼human papillomavirus.
aMedian.
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factors for ICC and the positive association of ICC with decreasing
AFSI remained at each level of exposure for each of these
characteristics (Table 3). Similar associations were observed for
AFP. No interaction was observed between any of the examined
risk factors and AFSI. Although not statistically significant, the risk
linked to AFSI seemed to be stronger among parous women
compared with nulliparous women.
Age at first pregnancy and AFM were both directly correlated
with AFSI in these populations (Po0.001). Approximately, 92% of
women reported AFSI to be the same as AFM. One-quarter of
women reported AFP to be the same as AFSI. Cumulatively, 62.4%
of women reported giving birth within the first year of AFSI.
Among women with AFSI p16 years, 52.4% were pregnant within
the first year of sexual intercourse. Figure 1 shows the high
correlation between AFSI and AFP, and the similar decreasing risk
of ICC with increasing age of AFSI/AFP. Given the high correlation
between the two variables, we did not adjust for AFSI in the AFP
final model and vice versa.
We further evaluated the combined effect of AFP and AFSI on
the risk of cervical cancer (Table 4). An increased risk emerged in
subsequent strata of decreasing AFP with decreasing AFSI. Given
this combined effect, we assessed the latency period (AFP AFSI)
between these two events to clarify whether it affected the cervical
cancer risk. Although there was no statistical difference across
strata, the data suggested that within each AFSI strata, women with
a latency period for a subsequent pregnancy of o2 years may be at
a slight increased risk compared with women with a larger time
gap (data not shown).
DISCUSSION
The IARC/ICO series of case–control studies remain the largest
set of aetiological investigations on ICC that fully addresses the
role of HPV DNA and of the independent established cofactors.
This is probably also the largest dataset reporting on ICC in the
developing world in which early AFSI, AFP and high parity are
prevalent phenomenons. The results show that early AFSI and
early AFP are risk factors for cervical cancer, irrespective of other
known risk factors for the disease. The data presented show a
possible additional increase in risk when the early event of first
sexual intercourse is shortly followed by a pregnancy.
The mechanism by which the early experience of first sexual
intercourse and first pregnancy could influence the risk of cervical
carcinogenesis may be explained by the steroid hormonal
influence on HPV infection and on the host’s immune response
to HPV during pre-adolescence and adolescence. The transforma-
tion zone of the cervical epithelium has been recognised as the site
in which HPV infection tends to cause cancer, and the suscepti-
bility of this area is believed to be related to its denudation of the
stratified epithelium, thus facilitating exposure of the basal layer to
HPV with minimal trauma. Biological immaturity during adoles-
cence has also been proposed as an additional susceptibility factor
(Moscicki et al, 1989; Elson et al, 2000; Singer and Monaghan,
2000). During adolescence and pregnancy, the cervix is exposed to
augmented levels of hormonal changes (Singer and Monaghan,
2000), in which oestrogen stimulation facilitates acidification of
the vaginal cavity, a determinant of squamous metaplasia when the
endocervical epithelial everts (Elson et al, 2000). When this
oestrogen-stimulated metaplastic transformation occurs in the
presence of HPV, the probability of cell transformation increases,
resulting in neoplastic changes (Elson et al, 2000; Shai et al, 2007,
2008; Hwang et al, 2009). This phenomenon is dependent
primarily on parity, and is more likely to occur during the first
pregnancy rather than subsequent pregnancies (Singer and
Monaghan, 2000). Although it has been postulated that these
metaplastic changes are also influenced by the trauma and repair
experienced during delivery, no increased risk for cervical
carcinoma was observed in this same dataset when traumatic
partition was evaluated (Munoz et al, 2002).
Increased risks of cervical carcinoma have been identified in
women with long-term use of hormonal steroids (Moreno et al,
2002) and those who are highly parous (Munoz et al, 2002).
In addition, HPV-16 transgenic mouse models have shown that
those treated with longer durations of oestrogen were more likely
to develop larger tumours and have a significantly higher number
of tumours than those treated with a shorter duration (Elson et al,
2000; Brake and Lambert, 2005), supporting the human observa-
tions of a susceptible cervix to carcinogenic progression by conti-
nuous exogenous oestrogen exposure or increased endogenous
oestrogen levels. If indeed oestrogen is needed for cervical
carcinogenesis, close follow-up of young women and of their
early pregnancies may be relevant to further understanding the
role of steroids in the acquisition and persistence of HPV
infections.
The influence of oestrogens on immune response may offer
another explanatory effect (Mitrani-Rosenbaum et al, 1989; Arbeit
et al, 1996), particularly during the follicular phase of the ovarian
cycle and pregnancy, when levels of oestrogens are increased up to
3–8-fold the normal levels (Duncan et al, 1994; Marzi et al, 1996;
Jabbour et al, 2008). The higher density of oestrogen receptors
and their expression in the transformation zone may synergise
with the effects of HPV oncoproteins, decreasing levels of cytotoxic
cytokines that may down-regulate the cervical cell-mediated
immune response, which favour persistent HPV infections instead
of clearance (Marzi et al, 1996; Giannini et al, 1998; 2002;
Jacobs et al, 2003). Additional research is needed to further
understand the interaction between oestrogens and the regulation
of immunomodulators, which may contribute to anti-tumour
immunity.
The varying results between studies regarding the roles of AFSI
and AFP may reflect the true differences between the study
populations. In our study, the similar increased risks shown for
AFSI and AFP may, in general, reflect the fact that in most
developing countries women initiate these events at an early age,
Table 2 Effect of different strategies of multivariate model adjustments on the association between age at first sexual intercourse and risk of ICC (from
IARC case–control studies)
Age and centre adjusted HPV unadjusted
a HPV adjusted
a HPV-positive only
a
Sexual debut Cases n (%) Controls n (%) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI) Odds ratio (95% CI)
X21 years 341 (16.9) 656 (35.4) 1.00 1.00 1.00 1.00
17–20 years 813 (40.2) 667 (36.0) 2.44 (1.07–2.87) 1.80 (1.50–2.16) 1.78 (1.32–2.39) 2.10 (1.49–2.97)
p16 years 710 (35.1) 396 (21.4) 4.09 (3.38–4.94) 2.31 (1.85–2.87) 2.09 (1.48–2.96) 2.48 (1.65–3.73)
P-trend o0.001 o0.001 o0.001
Abbreviations: HPV¼human papillomavirus; ICC¼invasive cervical carcinoma; IARC¼International Agency for Research on Cancer; CI¼confidence interval.
aAdjusted for age,
study country, lifetime number of partners (1, X2), parity (0, 1–4, X5), and education (never, primary, secondary).
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Number of cases/controls Odds ratio (95% CI)
a Odds ratio (95% CI)
b P-trend
Parity
Nulliparous
X21 years 14/40 1.00 1.00
17–20 years 7/14 1.88 (0.53–6.66) 1.61 (0.40–6.57)
p16 years 7/6 3.60 (0.83–15.52) 1.50 (0.17–13.55) 0.56
Ever parous
X21 years 327/614 1.00 1.00
17–20 years 804/645 2.47 (2.07–2.94) 1.97 (1.63–2.36)
p16 years 703/387 4.10 (3.36–4.99) 2.59 (2.08–3.21) o0.001
P-heterogeneity between AFSI and ever parous¼0.64
Parity (1–4 births)
X21 years 171/399 1.00 1.00
17–20 years 273/287 2.58 (1.98–3.35) 1.99 (1.51–2.62)
p16 years 169/115 4.72 (3.41–6.54) 2.71 (1.89–3.87) o0.001
Parity (X5 births)
X21 years 156/215 1.00 1.00
17–20 years 531/358 2.01 (1.57–2.59) 1.71 (1.32–2.23)
p16 years 534/272 2.88 (2.19–3.78) 2.08 (1.55–2.78) o0.001
P-heterogeneity between AFSI and parous groups (nulliparous, 1–4 births, and X5 births)¼0.90
Oral contraceptive use
Never
X21 years 218/400 1.00 1.00
17–20 years 453/364 2.33 (1.87–2.90) 1.77 (1.40–2.25)
p16 years 376/184 4.28 (3.29–5.55) 2.45 (1.82–3.29) o0.001
1–4 years
X21 years 64/162 1.00 1.00
17–20 years 117/114 2.64 (1.76–3.94) 1.67 (1.07–2.61)
p16 years 111/89 3.94 (2.53–6.13) 1.95 (1.15–3.30) 0.01
X5 years
X21 years 36/52 1.00 1.00
17–20 years 124/72 3.26 (1.85–5.72) 2.46 (1.36–4.46)
p16 years 96/49 4.48 (2.39–8.40) 2.80 (1.38–5.65) 0.006
Smoking
Never
X21 years 272/569 1.00 1.00
17–20 years 587/552 2.34 (1.93–2.83) 1.68 (1.36–2.06)
p16 years 550/348 3.76 (3.03–4.67) 2.06 (1.61–2.64) o0.001
Ever
X21 years 67/85 1.00 1.00
17–20 years 221/113 2.73 (1.81–4.13) 2.32 (1.50–3.60)
p16 years 152/43 5.63 (3.42–9.27) 3.62 (2.10–6.26) o0.001
Lifetime number of sexual partners
Monogamous
X21 years 270/569 1.00 1.00
17–20 years 529/499 2.33 (1.92–2.83) 1.80 (1.46–2.22)
p16 years 349/214 3.89 (3.05–4.96) 2.38 (1.83–3.11) o0.001
Partners 41
X21 years 69/74 1.00 1.00
17–20 years 280/151 2.03 (1.37–3.01) 1.74 (1.15–2.63)
p16 years 352/156 2.75 (1.84–4.11) 2.14 (1.39–3.28) 0.001
P-heterogeneity¼0.36
Education
Never go to school
X21 years 54/57 1.00 1.00
17–20 years 255/155 1.68 (1.09–2.60) 1.46 (0.93–2.30)
p16 years 402/173 2.41 (1.55–3.75) 2.09 (1.31–3.35) 0.001
Primary school
X21 years 164/238 1.00 1.00
17–20 years 404/311 1.99 (1.54–2.56) 1.62 (1.24–2.12)
p16 years 236/167 2.51 (1.87–3.39) 1.71 (1.24–2.36) 0.001
Secondary school
X21 years 118/359 1.00 1.00
17–20 years 150/198 2.68 (1.95–3.68) 2.29 (1.65–3.20)
p16 years 72/55 4.79 (3.07–7.47) 3.36 (2.07–5.47) o0.001
P-heterogeneity¼0.08
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distinguish from one another. In contrast, results of studies in
more developed countries where there is a longer latency period
between sexual initiation and AFP, as in Spain, the US (Brinton
et al, 1987) or Italy (Parazzini et al, 1989) tend to show an
increased risk with early AFSI but not with AFP as first
pregnancies tend to occur much later. It is interesting that, in
countries like the UK, where the rates of teenage pregnancies are
high, women with AFSI of p17 years had a 2–3-fold increased risk
for cervical cancer compared with those with AFSI X20 years
(Green et al, 2003). Consistently, women with an early AFP of
15–19 years had a two-fold increased risk for cervical cancer
compared with those with AFP X25 years (Green et al, 2003).
These observations merit further exploration but, in aggregate,
tend to indicate a significant increase in risk of neoplastic disease
when early AFSI occurs (surrogate of early HPV exposure and a
period of increased cervical susceptibility) and is followed closely
by an early pregnancy (surrogate of early exposure to high
oestrogen levels).
Irrespective of their lifetime number of sexual partners, women
have a similar increased risk of ICC with early AFSI as shown by
the 2.4-fold risk among monogamous women with AFSI p16 years
as compared with the 2.2-fold risk among women with 41 lifetime
number of sexual partners. It has long been suggested that a
cervical cancer risk will also depend on the sexual history of the
woman’s male partner in addition to her own behaviour (Skegg
et al, 1982). This is particularly relevant in societies where most
women are virgins at marriage and monogamous thereafter, where
the incidence of cervical cancer for a population may vary
depending on the behaviour of the male partner. Of our study
women, 70% were monogamous. In several studies among
monogamous women, the risk of cervical cancer was reported to
be two to eight times for women with husbands who had multiple
partners (Pridan and Lilienfeld, 1971; Buckley et al, 1981; Brinton
et al, 1989). The sexual history of the male partner was not
evaluated in this analysis; however, promiscuity, history of other
STIS, and lack of male circumcision are factors that have been
associated with the male role in cervical carcinogenesis (Castellsa-
gue et al, 2003).
In interpreting our results, we must emphasise the difficulty in
fully disentangling a woman’s sexual and reproductive profile in
relation to her cancer risk (Schroder et al, 2003). We cannot
exclude misclassification bias if AFSI and the number of sexual
partners were inaccurately reported, leading to some residual
confounding, However, the presence of established risk factors for
ICC, use of oral contraceptives, smoking, and pap smear history
did not seem to significantly affect the strength of the association
between AFSI, AFP, and risk of ICC.
We examined the different stratified methodologies (unadjusted,
HPV-adjusted, and HPV-positive restricted) used to evaluate the
association between AFSI and risk of ICC traditionally employed in
the literature. This was done to exclude any spurious association
related to statistical adjustment and to clarify inconsistent findings
of the association found in earlier studies. Although in strict terms
restriction of analyses to HPV-positive cases and controls seemed
preferable, the consistency of the results across the three different
methods provides convincing evidence of the risk associated with
AFSI. Furthermore, these results indicate that for the evaluation of
other risk factors, adjusting for HPV status is not necessary as
the adjustments do not contribute to remove any confounding
effect.
Sexual practices in the world indicate that very early intercourse
might be occurring in adolescents with 44, 45 and 52% of girls
between the ages of 13–19 years reporting being sexually
experienced in Argentina, Botswana and Nigeria, respectively
Table 3 (Continued)
Number of cases/controls Odds ratio (95% CI)
a Odds ratio (95% CI)
b P-trend
Ever have a pap smear 12 months before study enrolment
Never
X21 years 183/320 1.00 1.00
17–20 years 434/371 2.20 (1.74–2.79) 2.29 (1.65–3.20)
p16 years 416/205 3.65 (2.79–4.78) 3.36 (2.07–5.47) o0.001
Ever
X21 years 158/336 1.00 1.00
17–20 years 379/296 2.65 (2.02–3.46) 1.92 (1.44–2.57)
p16 years 294/191 4.49 (3.32–6.06) 2.30 (1.63–3.24) o0.001
Abbreviations: CI¼confidence interval; AFSI¼age at first sexual intercourse.
aAdjusted for age and study centre.
bAdjusted for age, study country, lifetime number of partners
(1, X2), parity (0, 1–4, X5), and education (never, primary, secondary).
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Figure 1 Age at first sexual intercourse and age at first pregnancy
are highly correlated with the risk of invasive cervical cancer (P-
trendo0.001). Models were adjusted for age, centre, lifetime number of
sexual partners (1, 41), parity (0, 1–4, X5), and education (never,
primary, secondary).
Table 4 Interaction between age at first pregnancy and age at first sexual
intercourse in the risk of cervical cancer
Age at first pregnancy
Age at sexual debut X21 17–20 p16
X21 years 1.00
17–20 years 1.58 (1.22–2.03) 1.93 (1.58–2.36)
p16 years 2.17 (1.35–3.47) 2.28 (1.74–2.99) 2.36 (1.82–3.07)
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first sexual intercourse has been reported as forced in 5–15% of
cases, and in some extreme cases worldwide, the estimates range
from 21% among out-of-school adolescents in Botswana, 20%
among secondary schools in Peru, and 41% among young urban
females attending night schools in Peru. Among 15–30% of
sexually active girls aged 15–19 years report forced first sexual
intercourse (Brown et al, 2001). It is likely that the partners of
these adolescents who report sexual coercion are adult males who
are sexually experienced (Wellings et al, 2006) and at high risk of
HPV exposure. Globally, these exposures might affect a high
proportion of very young girls in areas of human strife, thus
adding child sexual abuse to the burden of a lifetime increased risk
of genital cancer.
Our study shows that women who initiate first sexual
intercourse and experience their first pregnancy at a young age
are at an increased risk of cervical cancer. The importance of
HPV-vaccination programmes targeting young adolescents before
first sexual intercourse can have a great effect in decreasing the
incidence of cervical cancer; additional efforts are required in
family planning and sexual education adapted to the extremely
variable sociocultural contexts in the world.
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